CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
argenx SE Company Snapshot
argenx SE operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares argenx SE with three other miscellaneous service companies in Europe: Oncodesign Sa of FRANCE (2020 sales of 25.50 million Euros [US$30.36 million] ), Uniqure NV of NETHERLANDS (32.70 million Euros [US$38.93 million] of which 100% was Pharmaceutical), and Brain Biotechnology Research and Information Network AG which is based in GERMANY (39.06 million Euros [US$46.50 million] of which 64% was BioIndustrial).

Sales Analysis. argenx SE reported sales of 36.43 million Euro (US$43.36 million) for the year ending December of 2020. This represents a sharp decrease of 47.8% versus 2019, when the company's sales were 69.78 million Euro. Contributing to the drop in overall sales was the 89.2% decline in Milestone Payments, from 28.09 million Euro to 3.02 million Euro. There were also decreases in sales in Research and Development Service Fees (F (down 84.2% to 3.06 million Euro) . However, these declines were partially offset by the increase in sales of Upfront Payments (up 35.7% to 30.35 million Euro) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
argenx SE
  Stock Performance Chart for argenx SE
 
  Stock Data: Recent Stock Performance:
  Current Price (4/9/2021): 233.30
(Figures in Euros )
1 Week -2.0%   13 Weeks -10.0%  
4 Weeks -0.8%   52 Weeks 79.7%  
 
argenx SE Key Data:
  Ticker: ARGX Country: Netherlands
  Exchanges: BRU Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2020 Sales 36,425,000
(Year Ending Jan 2021).
Employees: 336
  Currency: Euros Market Cap: 11,098,380,324
  Fiscal Yr Ends: December Shares Outstanding: 47,571,283
  Share Type: Actions Ordinaires Closely Held Shares:
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.